NOTCH1-induced T-cell leukemia in transgenic zebrafish

Area of Science:

• Genetics
• Molecular Biology
• Cancer Research

Background:

• Activating mutations in the NOTCH1 gene are implicated in approximately 60% of T-cell acute lymphoblastic leukemia (T-ALL) cases.
• Understanding the molecular pathways linking NOTCH1 alterations to leukemia is crucial for developing targeted therapies.

Purpose of the Study:

• To establish and utilize a zebrafish model for investigating the molecular mechanisms of human NOTCH1-induced T-cell leukemia.
• To explore potential genetic interactions and cooperative pathways involved in T-ALL development.

Main Methods:

• Generation of a zebrafish model with activating NOTCH1 mutations.
• Analysis of leukemia development, latency, and invasiveness in mosaic and stable transgenic fish.
• Cross-breeding stable transgenic lines with bcl2-overexpressing lines to assess synergistic effects.
• Gene expression analysis using reverse transcription-polymerase chain reaction (RT-PCR) to quantify Notch target genes.

Main Results:

• Mosaic zebrafish developed T-cell lymphoproliferative disease, exhibiting aggressive and lethal leukemia upon transplantation.
• Stable transgenic fish showed a longer latency period for leukemia onset.
• Co-expression of NOTCH1 and bcl2 significantly accelerated leukemia onset, demonstrating pathway synergy.
• Notch target genes (her6, her9) were highly expressed in induced leukemias.

Conclusions:

• The zebrafish model effectively recapitulates human NOTCH1-induced T-ALL and demonstrates a critical interaction between NOTCH1 and bcl2-mediated anti-apoptosis.
• This model is a powerful tool for genetic modifier screens to identify novel genes cooperating with NOTCH1 in T-ALL pathogenesis.